The PANcreatic Disease ReseArch (PANDoRA) consortium: Ten years' experience of association studies to understand the genetic architecture of pancreatic cancer
Jazyk angličtina Země Nizozemsko Médium print-electronic
Typ dokumentu časopisecké články, přehledy
Grantová podpora
26881
Cancer Research UK - United Kingdom
PubMed
37164172
DOI
10.1016/j.critrevonc.2023.104020
PII: S1040-8428(23)00108-7
Knihovny.cz E-zdroje
- Klíčová slova
- Chronic pancreatitis, Consortium, Genetic epidemiology, Intraductal papillary mucinous neoplasms, Pancreatic cancer, Pancreatic ductal adenocarcinoma, Pancreatic neuroendocrine tumors,
- MeSH
- duktální karcinom slinivky břišní * MeSH
- jednonukleotidový polymorfismus MeSH
- lidé MeSH
- nádory slinivky břišní * etiologie genetika MeSH
- rizikové faktory MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
Pancreatic cancer has an incidence that almost matches its mortality. Only a small number of risk factors and 33 susceptibility loci have been identified. so Moreover, the relative rarity of pancreatic cancer poses significant hurdles for research aimed at increasing our knowledge of the genetic mechanisms contributing to the disease. Additionally, the inability to adequately power research questions prevents small monocentric studies from being successful. Several consortia have been established to pursue a better understanding of the genetic architecture of pancreatic cancers. The Pancreatic disease research (PANDoRA) consortium is the largest in Europe. PANDoRA is spread across 12 European countries, Brazil and Japan, bringing together 29 basic and clinical research groups. In the last ten years, PANDoRA has contributed to the discovery of 25 susceptibility loci, a feat that will be instrumental in stratifying the population by risk and optimizing preventive strategies.
Azienda Ospedale Università di Padova Medicina di Laboratorio Padova Italy
Biomedical Center Faculty of Medicine in Pilsen Charles University Pilsen Czech Republic
Center for Translational Research in Oncology São Paulo Brazil
Department of Oncology Faculty of Medicine and Dentistry Palacky University Olomouc Czech Republic
Department of Pulmonary diseases Erasmus MC University Medical Center Rotterdam the Netherlands
Department of Surgery 1 University Hospital Olomouc Olomouc Czech Republic
Department of Surgery Erasmus MC University Medical Center Rotterdam the Netherlands
Department of Surgery The Pancreas Institute University and Hospital Trust of Verona Verona Italy
Departments of Oncology and Medicine Copenhagen University Hospital Herlev Denmark
Dept of Digestive Tract Diseases Medical University of Lodz Lodz Poland
Dept of Medicine University of Padova Medicina di Laboratorio Padova Italy
Dept of Surgery Oncology and Gastroenterology University of Padova Chirurgia Generale 1 Padova Italy
Dept of Surgery Oncology and Gastroenterology University of Padova Chirurgia Generale 3 Padova Italy
Division of Cancer Epidemiology C020 German Cancer Research Center Heidelberg Germany
Division of General and Transplant Surgery Pisa University Hospital Pisa Italy
Endoscopic Unit Department of Gastroenterology IRCCS Humanitas Research Hospital Milan Italy
Genomic Epidemiology Group German Cancer Research Center Heidelberg Germany
Institute for Translational Medicine Medical School University of Pécs Pécs Hungary
Instituto BIFI Universidad de Zaragoza Zaragoza Spain
Liverpool Experimental Cancer Medicine Centre University of Liverpool Liverpool United Kingdom
Meyer Children's Hospital IRCCS Florence Italy
Oncological Department Massa Carrara Azienda USL Toscana Nord Ovest Carrara Italy
Potenza Medica County Association Potenza Italy
Unit of Genetic Department of Biology University of Pisa Pisa Italy
Citace poskytuje Crossref.org
Commentary: Special Issue: Current Understanding of Colorectal and Pancreatic Cancers
Identification of novel genetic loci for risk of multiple myeloma by functional annotation
Exploring the Neandertal legacy of pancreatic ductal adenocarcinoma risk in Eurasians